Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ThermoGenesis Holdings, Inc. (THMO : NSDQ)
 
 • Company Description   
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.

Number of Employees: 41

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.26 Daily Weekly Monthly
20 Day Moving Average: 169,658 shares
Shares Outstanding: 1.90 (millions)
Market Capitalization: $2.40 (millions)
Beta: 2.59
52 Week High: $19.80
52 Week Low: $1.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -35.38% -37.83%
12 Week -48.78% -52.45%
Year To Date -60.63% -64.18%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2711 CITRUS ROAD
-
RANCHO CORDOVA,CA 95742
USA		 ph: 916-858-5100
fax: 916-858-5199		 ir@thermogenesis.com http://www.thermogenesis.com
 
 • General Corporate Information   
Officers
Chris Xu - Chief Executive Officer and Chairman
Haihong Zhu - Chief Operating Officer
Jeff Cauble - Chief Financial Officer
Vivian Liu - Director
Russell Medford - Director

Peer Information
ThermoGenesis Holdings, Inc. (CORR.)
ThermoGenesis Holdings, Inc. (RSPI)
ThermoGenesis Holdings, Inc. (CGXP)
ThermoGenesis Holdings, Inc. (BGEN)
ThermoGenesis Holdings, Inc. (GTBP)
ThermoGenesis Holdings, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 88362L209
SIC: 3821
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/23
Next Expected EPS Date: 08/10/23
Share - Related Items
Shares Outstanding: 1.90
Most Recent Split Date: 12.00 (0.02:1)
Beta: 2.59
Market Capitalization: $2.40 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.92 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.39
Price/Cash Flow: -
Price / Sales: 0.23
EPS Growth
vs. Year Ago Period: 46.16%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -3.42%
vs. Previous Quarter: -3.89%
ROE
03/31/23 - -316.97
12/31/22 - -317.39
09/30/22 - -290.36
ROA
03/31/23 - -71.26
12/31/22 - -57.71
09/30/22 - -52.23
Current Ratio
03/31/23 - 1.05
12/31/22 - 0.95
09/30/22 - 1.05
Quick Ratio
03/31/23 - 0.72
12/31/22 - 0.66
09/30/22 - 0.60
Operating Margin
03/31/23 - -138.10
12/31/22 - -108.84
09/30/22 - -102.61
Net Margin
03/31/23 - -139.01
12/31/22 - -107.51
09/30/22 - -102.61
Pre-Tax Margin
03/31/23 - -143.94
12/31/22 - -112.68
09/30/22 - -108.80
Book Value
03/31/23 - 2.63
12/31/22 - 3.20
09/30/22 - 4.46
Inventory Turnover
03/31/23 - 1.75
12/31/22 - 1.58
09/30/22 - 1.33
Debt-to-Equity
03/31/23 - 0.00
12/31/22 - 0.00
09/30/22 - 0.00
Debt-to-Capital
03/31/23 - 0.00
12/31/22 - 0.00
09/30/22 - 0.00
 

Powered by Zacks Investment Research ©